You are here

  • Home
  • Archive
  • Volume 69, Issue 7
  • Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial

Article metrics

Article menu
Download PDFPDF
Inflammatory bowel disease
Original research
Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial

 

Online download statistics by month:

Online download statistics by month: January 2020 to March 2024

AbstractFullPdf
Jan 20202336145120
Feb 20202806147143
Mar 20206046354
Apr 20202173323
May 20201652830
Jun 20203135282214
Jul 20201209162118
Aug 20204397466
Sep 20203695334
Oct 20203035145
Nov 20203206363
Dec 20202904047
Jan 20214043746
Feb 20217516575
Mar 20215395366
Apr 20214093646
May 20211564239
Jun 2021312225
Jul 2021514123
Aug 2021514728
Sep 2021373422
Oct 20213234928
Nov 20214214726
Dec 20213114831
Jan 20222556334
Feb 20223494222
Mar 20223355535
Apr 20224225327
May 20223953524
Jun 20222804120
Jul 20222133215
Aug 20223573721
Sep 20224914725
Oct 2022309388
Nov 20224916033
Dec 20223041614
Jan 20233923011
Feb 2023331249
Mar 20233093215
Apr 20232602812
May 20233262316
Jun 2023271177
Jul 202314594
Aug 2023164205
Sep 20232302215
Oct 20232772815
Nov 20233642815
Dec 20232331919
Jan 20242442419
Feb 20243352114
Mar 20243011516
Total2406025211882